| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/21/2004 | WO2004090551A2 Secreted polypeptide species associated with cardiovascular disorders |
| 10/21/2004 | WO2004090541A1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY |
| 10/21/2004 | WO2004090155A2 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 10/21/2004 | WO2004090151A2 Method for extracting collagen comprising microbial fermentation |
| 10/21/2004 | WO2004090142A2 Plants having modified growth characteristics and method for making the same |
| 10/21/2004 | WO2004090141A2 Method to increase stress tolerance in plants |
| 10/21/2004 | WO2004090139A1 Method for the construction of randomized gene sequence libraries in cells |
| 10/21/2004 | WO2004090135A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
| 10/21/2004 | WO2004090131A1 Inducible site-directed mutagenesis through conditional gene rescue |
| 10/21/2004 | WO2004090115A2 Renilla gfp mutants with increased fluorescent intensity and special shift |
| 10/21/2004 | WO2004090113A2 L53, a lung cancer associated antigen and uses thereof |
| 10/21/2004 | WO2004090109A2 Ccn3 compositions and methods |
| 10/21/2004 | WO2004090103A2 Identification of novel nogo-receptors and methods related thereto |
| 10/21/2004 | WO2004090097A2 Polynucleotide encoding a novel human p2x7 splice variant, hbmyp2x7v |
| 10/21/2004 | WO2004089987A1 Secreted polypeptide species associated with cardiovascular disorders |
| 10/21/2004 | WO2004089986A1 Antimicrobial peptide from transferrin family |
| 10/21/2004 | WO2004089984A1 Antigen recognizing antibody |
| 10/21/2004 | WO2004089983A2 Severe acute respiratory syndrome (sars) causing coronavirus |
| 10/21/2004 | WO2004089982A2 April variants and methods thereof |
| 10/21/2004 | WO2004089981A2 Antitumor effect of mutant bik |
| 10/21/2004 | WO2004089979A2 Adp-ribosylating toxin from listeria monocytogenes |
| 10/21/2004 | WO2004089978A2 Use of hcv proteins |
| 10/21/2004 | WO2004089976A1 Method of treatment |
| 10/21/2004 | WO2004089975A2 Peptides of irf-1 |
| 10/21/2004 | WO2004089973A2 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 10/21/2004 | WO2004089421A2 Methods for rational pegylation of proteins |
| 10/21/2004 | WO2004089404A1 Hemoglobin conjugate and the preparation method and its use |
| 10/21/2004 | WO2004089399A1 Novel uses of rfrp and ot7t022 |
| 10/21/2004 | WO2004089376A2 Identification and targeting of consensus sites by which dynorphin exerts its neurotoxic effects enables analgesia without neurotoxicity |
| 10/21/2004 | WO2004089310A2 High-throughput assay for virus entry and drug screening |
| 10/21/2004 | WO2004089302A2 Posh polypeptides, complexes and related methods |
| 10/21/2004 | WO2004089301A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 10/21/2004 | WO2004089295A2 Homogeneous and heterogeneous assay methods using nucleation centers and novel covalent chemistries for the rapid measurement of phosphorylation and de-phosphorylation |
| 10/21/2004 | WO2004089292A2 Immunomodulatory agents for treatment of inflammatory diseases |
| 10/21/2004 | WO2004089284A2 Targets for tumor growth inhibition |
| 10/21/2004 | WO2004089072A2 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 10/21/2004 | WO2004089071A1 Non-human mammals and animal cells containing a mutated alpha2/delta gene |
| 10/21/2004 | WO2004081024A3 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 10/21/2004 | WO2004072305A3 Atlastin |
| 10/21/2004 | WO2004067026A8 Regulation of allergen induced gene |
| 10/21/2004 | WO2004064856A3 Proteins involved in the regulation of energy homeostasis |
| 10/21/2004 | WO2004062567A3 Arterivirus marker vaccine |
| 10/21/2004 | WO2004062556A8 Methods for preventing and treating alzheimer’s disease (ad) |
| 10/21/2004 | WO2004056976A3 Process for coating cell-culture support |
| 10/21/2004 | WO2004056871A3 Peptides and their use for the treatment of hiv infections |
| 10/21/2004 | WO2004052932A3 Antibody (“11c7”) anti nogo a and its pharmaceutical use |
| 10/21/2004 | WO2004044168A3 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 10/21/2004 | WO2004042025A3 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 10/21/2004 | WO2004037189A3 Methods for vaccinating against malaria |
| 10/21/2004 | WO2004034971A3 Methods for treating and preventing sepsis using modified c1 inhibitor or fragments thereof |
| 10/21/2004 | WO2004022715A3 Cloning and characterization of the broad-spectrum resistance gene pi2 |
| 10/21/2004 | WO2004018637A3 New tumor suppressor genes and their uses |
| 10/21/2004 | WO2004010939A3 Methods of using non-human animal apoliprotein a-i protein |
| 10/21/2004 | WO2004009032A3 Method and composition for treating and preventing hepatitis b infection and symptoms thereof |
| 10/21/2004 | WO2004003159A3 Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders |
| 10/21/2004 | WO2003104431A3 Transgenic mammals expressing polyglutamine |
| 10/21/2004 | WO2003104419A3 Cancer-linked gene as target for chemotherapy |
| 10/21/2004 | WO2003031582A3 Novel acidic mammalian proteins and polynucleotides encoding the same |
| 10/21/2004 | WO2003027266A3 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 10/21/2004 | WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
| 10/21/2004 | WO2003025142A3 Novel nucleic acids and secreted polypeptides |
| 10/21/2004 | WO2003025120A3 Clasp membrane proteins |
| 10/21/2004 | WO2003024392A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/21/2004 | WO2003010190A3 Peptide screen |
| 10/21/2004 | WO2002086077A3 Co-expression of zein proteins |
| 10/21/2004 | WO1995027066A9 Dna encoding ubiquitin conjugating enzymes |
| 10/21/2004 | US20040210967 Genes for controlling floral development in orchid |
| 10/21/2004 | US20040210966 Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants |
| 10/21/2004 | US20040210965 Comprises nucleotide sequences coding pesticidal protein for use in transformation and propagation of insect resistant crop plants; tissue engineering and biological pest control |
| 10/21/2004 | US20040210964 AXMI-009, a delta-endotoxin gene and methods for its use |
| 10/21/2004 | US20040210963 Genes encoding proteins with pesticidal activity |
| 10/21/2004 | US20040210962 Nucleotide sequences coding protein associated with controlling mitochondrial recombination for use in identifying RNA sequence which suppress sequence insertion into mitochondrial genomes |
| 10/21/2004 | US20040210957 Cloning and characterization of the broad-spectrum resistance gene P12 |
| 10/21/2004 | US20040210956 Preparing expression vector comprising nucleotide sequences coding spider silk protein, transforming arabidopsis and recover protein; plant bioreactors |
| 10/21/2004 | US20040210952 Transgenic animals |
| 10/21/2004 | US20040210950 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (CALSARCINS) |
| 10/21/2004 | US20040210042 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 10/21/2004 | US20040210039 Keratin-based products and methods for their productions |
| 10/21/2004 | US20040210038 Il-1 eta DNA and polypeptides |
| 10/21/2004 | US20040210037 Comprises major histocompatibility complex fusion protein for use in treating and/or preventing cancer, infection, allergies and autoimmune diseases |
| 10/21/2004 | US20040210035 Major histocompatibility complex epitope peptides for detection and treatment of cell proliferative disorders |
| 10/21/2004 | US20040209999 Synthesis of polypeptides by amidation of amino acids and chlorotrityl chloride linking |
| 10/21/2004 | US20040209839 Human peroxisome proliferator activated receptor gamma |
| 10/21/2004 | US20040209834 mouse double minute (MDM); determining the mdm2-dependent growth activity of a cell by introducing vectors for expressing a p53 polypeptide or fragment into the cell, and measuring the growth of the cell |
| 10/21/2004 | US20040209833 Transgenic fish germline expression driven by liver fatty acid binding (L-FABP) gene promoter and applications thereof |
| 10/21/2004 | US20040209830 System for monitoring the expression of transgenes |
| 10/21/2004 | US20040209817 Methods and compositions for the treatment of peripheral artery disease |
| 10/21/2004 | US20040209816 Treatment for diabetes |
| 10/21/2004 | US20040209812 Use of erythropoietin in stroke recovery |
| 10/21/2004 | US20040209808 antiproliferative agents; monoclonal/polyclonal antibodies; drug screening; kits |
| 10/21/2004 | US20040209804 comprises calcium for stable, extendend release; improved bioavailability; protamines; for treatment of turner's syndrome, crohn's disease, burns |
| 10/21/2004 | US20040209801 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; kits |
| 10/21/2004 | US20040209800 Use of mx gtpases in the prognosis and treatment of cancer |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/21/2004 | US20040209797 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 10/21/2004 | US20040209338 Silica mesoporous aerogels having three-dimensional nanoarchitecture with colloidal gold-protein superstructures nanoglued therein |
| 10/21/2004 | US20040209336 Using transgenic streptomyces to ferment polyketide for use in the treatment of cancer |
| 10/21/2004 | US20040209330 Preparing immunoglobulins for use in diagnosis, prevention and treatment of psoriasis, inflammation and infection |
| 10/21/2004 | US20040209329 Nucleotide sequences coding insecticidal protein membrane receptor for use in generating insect resistant plants; biological pest control; drug screening and design |
| 10/21/2004 | US20040209328 Human tumor necrosis factor receptor TR16 |